BridgeMD
New treatment option for Mild Concussion
Official title A New Generation of Magnetoencephalographs for High Speed Functional Brain Imaging
ClinicalTrials.gov ID: NCT06244472
What this study is testing
- What it's testing
- The goal is to perform a first evaluation of the capabilities of a new generation of non-invasive magnetoencephalography whole head device using optically pumped magnetometers using Helium 4 as the sensitive element (OPM He4) to record brain magnetic activities. The investigators will record 1) healthy subjects stimulated with visual, auditory, somesthesic and motor stimuli and 2) athletes who suffered a mild concussion.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Healthy volunteers:
- Age 18 to 70
- Strongly motivated to participate to the study
- Signed informed consent for the study
You likely can't join if
- major cognitive deficit and unable to understand the instructions
- previous neurology or psychiatric or sleep pathologies
- Woman with a positive pregnancy test during the inclusion.
- people under guardianship, curatorship or safeguard of justice protection
- people deprived of their liberty
- Subject not affiliated to a social security system.
See the full eligibility criteria
- Healthy volunteers:
- Age 18 to 70
- Strongly motivated to participate to the study
- Signed informed consent for the study
- major cognitive deficit and unable to understand the instructions
- previous neurology or psychiatric or sleep pathologies
- Woman with a positive pregnancy test during the inclusion.
- people under guardianship, curatorship or safeguard of justice protection
- people deprived of their liberty
- Subject not affiliated to a social security system.
- Subject's refusal to be informed if an abnormality is detected during MEG and MRI scans
- Subject with common contraindications to MEG and MRI examination :
- Metal in the body incompatible with performance of the examination (pacemaker, implantable pump, neurostimulator, cochlear implant, auditory prothesis, metalic prothesis, intracerebral clip, implantable defibrillator...
- Claustrophobia people who suffered a mild concussion: Inclusion Criteria:
- Male aged from 18 to 40
- Strongly motivated to participate to the study
- Signed informed consent for the study
- Mild concussion confirmed by the club doctor and a neurologist neurologist in the three weeks preceding the experiment Exclusion Criteria:
- major cognitive deficit and unability to understand the instructions
- previous neurology or psychiatric or sleep pathologies except mild concussion
- Woman with a positive pregnancy test during the inclusion.
- people under guardianship, curatorship or safeguard of justice protection
- people deprived of their liberty
- Subject not affiliated to a social security system
- Subject's refusal to be informed if an abnormality is detected during MEG and MRI scans
- Subject with common contraindications to MEG and MRI examination :
- Metal in the body incompatible with performance of the examination (pacemaker, implantable pump, neurostimulator, cochlear implant, auditory prothesis, metalic prothesis, intracerebral clip, implantable defibrillator...
- Claustrophobia
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
- Lyon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France; Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.